Pharmaceutical giant Johnson & Johnson plans to start testing children for coronavirus vaccine Reuters.
Reuters reported on Friday that the company soon plans to test an experimental vaccine candidate for people aged 12 to 18.
Our country is engaged in a historic battle against the coronavirus.Add change to your Facebook Either Twitter Feed to always follow the news.
Jerald Sadoff, a senior consultant for Johnson & Johnson’s vaccine department, said at a meeting held by the Centers for Disease Control and Prevention (CDC): “We plan to do our best to get the child into the child as quickly as possible, but in terms of safety Be very cautious.”
Sadov said the company also plans to test children under 12 years old if it proves to be safe among children aged 12 to 18.
Most COVID-19 vaccine trials are aimed at whether the vaccine is safe and effective for adults. Pfizer has conducted phase three trials in the United States and has produced one of four vaccine candidates. The company recently began testing its vaccine candidates in children.
Although there are far fewer children suffering from COVID-19 than adults, they can still contract the virus and spread it to others.
Johnson & Johnson started the third phase of its vaccine trial last month, with the goal of recruiting 60,000 participants. After the participant had a stroke, the company had to suspend the trial earlier this month. An independent committee investigated the incident and determined that the incident was not related to the vaccine, and the trial resumed this week.
It is not uncommon for some participants to get sick during large-scale vaccine trials, and most will recover shortly after the suspension, so the safety of the case can be assessed.
You need to understand the contents of the coronavirus immediately
What are overspread and superspread, and what do they mean for coronavirus?
California confirmed the first simultaneous flu and coronavirus infection in a patient
Nearly 90,000 new daily cases of COVID-19 infection in the United States, a record-breaking record
What we can learn from the deadly second wave of the 1918 pandemic
Studies have shown that immunity after Covid-19 infection may last for five months